Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Grunert
Chadrick Adam Nathaniel Jordan Grunert, Vancouver CA
| Patent application number | Description | Published |
|---|---|---|
| 20100305241 | DERIVATIVES OF NATIVE LIGNIN - The present invention provides derivatives of native lignin having a certain aliphatic hydroxyl content. Surprisingly, it has been found that consistent and predictable antioxidant activity may be provided by selecting for derivatives of native lignin having a certain aliphatic hydroxyl content. | 12-02-2010 |
| 20100305242 | DERIVATIVES OF NATIVE LIGNIN FROM HARDWOOD FEEDSTOCKS - The present invention provides hardwood derivatives of native lignin having a certain aliphatic hydroxyl content. Surprisingly, it has been found that consistent and predictable antioxidant activity may be provided by selecting for derivatives of native lignin having a certain aliphatic hydroxyl content. | 12-02-2010 |
| 20100305243 | DERIVATIVES OF NATIVE LIGNIN FROM SOFTWOOD FEEDSTOCKS - The present invention provides softwood derivatives of native lignin having a certain aliphatic hydroxyl content. Surprisingly, it has been found that consistent and predictable antioxidant activity may be provided by selecting for derivatives of native lignin having a certain aliphatic hydroxyl content. | 12-02-2010 |
| 20100305244 | DERIVATIVES OF NATIVE LIGNIN FROM ANNUAL FIBRE FEEDSTOCKS - The present invention provides derivatives of native lignin having a certain aliphatic hydroxyl content. Surprisingly, it has been found that consistent and predictable antioxidant activity may be provided by selecting for derivatives of native lignin having a certain aliphatic hydroxyl content. | 12-02-2010 |
Fritz Grunert, Freiburg DE
| Patent application number | Description | Published |
|---|---|---|
| 20110236347 | Monoclonal Anti-Claudin 1 Antibodies for the Inhibition of Hepatitis C Virus Infection - The present invention provides monoclonal antibodies that specifically bind to the extracellular domain of human Claudin-1 on the cell surface, thereby inhibiting HCV entry into susceptible cells and preventing HCV infection of these cells; and hybridoma cell lines which produce such monoclonal antibodies. Also provided are reagents that comprise such antibodies, and pharmaceutical compositions comprising such antibodies. Methods of treating or preventing HCV infection by administration of an inventive monoclonal antibody, or a pharmaceutical composition thereof are also described. | 09-29-2011 |
Jan Grunert, Chemnitz DE
| Patent application number | Description | Published |
|---|---|---|
| 20090056857 | METHOD FOR PRODUCING A MULTIDIRECTIONAL FABRIC WEB - The invention relates to a method for the continuous production of a multidirectional fabric web. The object of the invention is to create a method for the continuous production of a multidirectional fabric web that has a material layer running in a longitudinal direction and thus has sufficient stability against distortions in the fabric. This object is achieved according to the invention in that a continuous fold-winding process of at least one fiber layer running at an angle to the direction of extension of the fabric web to be produced takes place with the enclosing of at least one material web ( | 03-05-2009 |
Jan Grunert, Hamburg DE
| Patent application number | Description | Published |
|---|---|---|
| 20100314378 | GLASS PANE AND GLASS PANE ARRANGEMENT - The invention relates to a glass pane ( | 12-16-2010 |
Klaus Grunert, Berlin Reinickendorf DE
| Patent application number | Description | Published |
|---|---|---|
| 20110302967 | LAUNDRY DRYING UNIT HAVING A LINT SCREEN ARRANGED WITHIN A PROCESS AIR CIRCUIT AND A METHOD FOR OPERATING SAID LAUNDRY DRYING UNIT - A laundry drying unit includes a process air circuit and a component arranged in the process air circuit. Provided above the component is a washing tank for dispensing a cleaning fluid, with a flow of cleaning fluid dispensed from the washing tank to the component being controlled by a controllable valve. The valve can be controlled on the basis of an amount of cleaning fluid in the washing tank. | 12-15-2011 |
Lawrence A. Grunert, Lombard, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20110039372 | MEMS PACKAGE AND A METHOD FOR MANUFACTURING THE SAME - A method is provided for manufacturing a plurality of packages. The method comprises the steps of: applying a means for adhering two or more covers to a substrate; positioning the two or more covers onto the substrate to create one or more channels bounded by the two or more covers and the substrate; coupling the covers to the substrate; depositing a material into the one or more channels; performing a process on the material to affix the material; and singulating along the channels to create the plurality of packages. | 02-17-2011 |
Lothar Grunert, Biblis DE
| Patent application number | Description | Published |
|---|---|---|
| 20100176080 | CLOSURE WITH MEMBRANE AND ROTATABLE PROTECTIVE CAP - A closure ( | 07-15-2010 |
Norbert Grunert, Juan-Ies-Pins FR
| Patent application number | Description | Published |
|---|---|---|
| 20090180464 | METHOD AND SYSTEM FOR BLUETOOTH CONDITIONAL SYNCHRONIZATION - Aspects of a method and system for Bluetooth conditional synchronization are provided. In this regard, a synchronization code of a piconet may be included in each transmitted Bluetooth packets and a portion of the received synchronization code may be used for a synchronization process. The received synchronization code may be selectively sampled at a Bluetooth device. The Bluetooth device may determine a puncturing pattern to detect selected samples in the received synchronization code. The punctured received synchronization code may correlate to a reference code derived from a Bluetooth device address of the master device. The correlation value may be compared to a predetermined threshold value to indicate a success or a failure of the synchronization process. The threshold value as well as the puncture pattern may be user specific or centrally controlled, and they may be programmed or updated dynamically based on various conditions. | 07-16-2009 |
Norbert Grunert, Sophia Antipolis FR
| Patent application number | Description | Published |
|---|---|---|
| 20110319020 | METHOD AND SYSTEM FOR MULTI-STAGE DEVICE FILTERING IN A BLUETOOTH LOW ENERGY DEVICE - A Bluetooth low energy (BLE) device receives advertising packets from an advertising BLE device. The BLE device filters the received advertising packets utilizing hardware to search for the advertiser. If the advertiser is not found by the hardware, the packet filtering continues utilizing firmware. Device identity information, comprising non-private and/or private device identities, of preferred BLE devices is partitioned to form a different white list for the hardware, firmware, and host, respectively, to concurrently support privacy and white listing. If the advertiser is found by the hardware, the hardware sends a response to the advertiser following a successful CRC check performed in the hardware. If the advertiser is found by the firmware, the device identity information of the advertiser is inserted in the white list for the hardware. The host may be awakened based on the device configuration and/or attribute type information of the received advertising packets. | 12-29-2011 |
Norbert Grunert, Juan-Les-Pines FR
| Patent application number | Description | Published |
|---|---|---|
| 20120003942 | METHOD AND SYSTEM FOR SIGNAL STRENGTH MEASUREMENT - In a radio comprising a transmitter and a receiver, transmission and reception of signals may be controlled based on received signal strength measurements from a signal strength indicator module and transmitted signal strength measurements from the signal strength indicator module. For the transmitted signal strength measurements, the shared signal strength indicator module may measure signal strength of a signal output by a power amplifier. For the received signal strength measurements, the shared signal strength indicator module may measure signal strength of a received signal. A capacitance coupled to an output of the power amplifier may be configured based on a frequency of the signal output by the power amplifier. A gain of the power amplifier may be controlled based on the transmitted signal strength measurements. For the transmitted signal strength measurements, an analog-to-digital converter may process the signal output by the power amplifier. | 01-05-2012 |
Veit Peter Grunert, Munich DE
| Patent application number | Description | Published |
|---|---|---|
| 20110151581 | TRIGGER ASSAY FOR DIFFERENTIATING BETWEEN RHEUMATIC AND NON-RHEUMATIC DISORDERS - The present invention provides for a method for excluding a non-rheumatic disorder as cause of a musculoskeletal complaint of a subject including determining as to whether at least one autoantibody or antigen which is indicative for at least one rheumatic disorder is present in a sample obtained from the subject, wherein the presence of the autoantibody or antigen allows to exclude a non-rheumatic disorder as cause of a musculoskeletal complaint of a subject. Accordingly, it provides for a method that triggers the next steps in diagnosing the cause of a musculoskeletal complaint of a subject—either further diagnosis of a rheumatic disorder or of a non-rheumatic disorder to confirm the initial diagnosis. Also provided is a kit for excluding a non-rheumatic disorder as cause of a musculoskeletal complaint of a subject as well as uses of the kit. | 06-23-2011 |
Veit Peter Grunert, Muenchen DE
| Patent application number | Description | Published |
|---|---|---|
| 20090075312 | ASSESSING COLORECTAL CANCER BY MEASURING OSTEOPONTIN AND CARCINOEMBRYONIC ANTIGEN - The present invention relates to a method aiding in the assessment of colorectal cancer (=CRC). It discloses the use of a marker combination comprising osteopontin and carcinoembryonic antigen in the assessment of colorectal cancer. Furthermore, it especially relates to a method for assessing colorectal cancer from a liquid sample, derived from an individual by measuring at least the markers osteopontin and carcinoembryonic antigen in said sample. The marker combination comprising osteopontin and carcinoembryonic antigen can, e.g., be used in the early detection of colorectal cancer or in the surveillance of patients who undergo therapy, e.g., surgery. | 03-19-2009 |
| 20090270272 | ASSESSING RISK OF DISEASE PROGRESSION IN RHEUMATOID ARTHRITIS PATIENTS - Disclosed is an in vitro method aiding in the further assessment of patients suffering from rheumatoid arthritis. The method especially is used in assessing whether an RA patient is at risk of disease progression. The method is for example practiced by analyzing biochemical markers, comprising measuring in a sample the concentration of at least C-reactive protein (CRP) and interleukin-6 and correlating the concentrations determined to the likelihood of an underlying rapidly progressing form of RA. A patient at high risk of a rapidly progressing disease might be a patient in need for treatment or if already treated in need for a different and more effective treatment. The invention also relates to the use of a marker panel comprising C-reactive protein and interleukin-6 in the assessment of a patient with rheumatoid arthritis and it teaches a protein array device and kit, respectively, for performing the method of the invention. | 10-29-2009 |
| 20110129861 | MEASUREMENT OF ANTI-CCP AND SERUM AMYLOID A METHOD TO ASSESS RHEUMATOID ARTHRITIS - The present invention relates to a method aiding in the assessment of rheumatoid arthritis. The method especially is used in assessing the absence or presence of rheumatoid arthritis in vitro. It can be best practiced by analyzing biochemical markers, comprising measuring in a sample the concentration of anti-CCP and serum amyloid A and correlating the concentrations determined to the absence or presence of rheumatoid arthritis. To further improve the assessment of RA in a method of this invention the level of one or more additional marker may be determined together with anti-CCP and serum amyloid A and be correlated to the absence or presence of RA. The invention also relates to the use of a marker panel comprising anti-CCP and serum amyloid A in the diagnosis of rheumatoid arthritis and it teaches a kit for performing the method of the invention. | 06-02-2011 |